HDAC9 and neoplasm: HDAC inhibitors have multiple functions in immunomodulatory activities, including the promotion of the expression of MHC I molecule, tumor antigens, PD-L1, and T cell chemokines, induction of immunogenic cell death hallmarks in tumor cells, and decreasing Treg cells (13, 56, 57).